A drug for a treatment of a breast cancer, comprising antler and ginseng as a sovereign drug, wherein the drug is made of the antler and the ginseng as the sovereign drug, angelicae sinensis radix and radix paeoniae alba as an adjuvant drug, and combined with radix bupleuri, scutellariae radix, cyperi rhizoma, and thunberg fritillary bulb;
- wherein the drug, in parts by weight, comprises:
- 12 parts of the antler, 3 parts of the ginseng, 10 parts of the angelicae sinensis radix, 10 parts of the radix paeoniae alba, 5 parts of the radix bupleuri, 5 parts of the scutellariae radix, 10 parts of the cyperi rhizoma, and 10 parts of the thunberg fritillary bulb.